Assessment and Plan: Difference between revisions
Jump to navigation
Jump to search
Added F+N |
No edit summary |
||
| Line 7: | Line 7: | ||
CHF - [[HFrEF exacerbation (Assessment and Plan)|HFrEF exacerbation]] | CHF - [[HFrEF exacerbation (Assessment and Plan)|HFrEF exacerbation]] | ||
[[ | [[Syncope (Assessment and Plan)|Syncope]] | ||
== Endocrine: == | |||
== Hematology: == | == Hematology: == | ||
[[Macrocytic anemia (Assessment and Plan)|Macrocytic anemia]] | [[Macrocytic anemia (Assessment and Plan)|Macrocytic anemia]] | ||
== Oncology: == | == Oncology: == | ||
| Line 35: | Line 31: | ||
Cardiac Transplant Evaluation | Cardiac Transplant Evaluation | ||
[[Pulmonary embolism (Assessment and Plan)|Pulmonary embolism]] | |||
Tumor lysis syndrome | Tumor lysis syndrome | ||
[[Microcytic anemia (Assessment and Plan)|Microcytic anemia]] | |||
[[Anemia (Assessment and Plan)|Anemia]] | |||
[[Hypercalcemia (Assessment and Plan)|Hypercalcemia]] | |||
NSTEMI | NSTEMI | ||
STEMI | STEMI | ||
Latest revision as of 21:31, 1 October 2018
Welcome to the Assessment and Plan project page.
Cardiology:
CHF - HFrEF exacerbation
Endocrine:
Hematology:
Oncology:
Pulmonary:
Other
Assessment and Plan Project team
Project Leader: William J Gibson MD, PhD
Pages to add
HFpEF exacerbation
Ventricular Assist Device Evaluation (LVAD, BiVAD evaluation)
Cardiac Transplant Evaluation
Tumor lysis syndrome
NSTEMI
STEMI